Insulin Resistance

Insulin Resistance and the Markers That Reveal It

Insulin resistance biomarkers are blood signals that show how well your cells respond to insulin and how hard your pancreas must work to keep sugar in a healthy range. They come from the organs that govern energy use—the pancreas, liver, muscles, fat tissue, and the immune system—and together reveal the ongoing tug‑of‑war between insulin, glucose, and fats. Core markers reflect insulin production (insulin, C‑peptide), circulating sugar (glucose), and fat handling (triglycerides, HDL cholesterol). Others suggest how the liver responds to insulin (liver enzymes), how much fat is being released into the bloodstream (free fatty acids), and whether there is quiet, chronic inflammation (C‑reactive protein). Hormones made by fat cells (adipokines such as adiponectin and leptin) add insight into fat tissue health and insulin sensitivity. By measuring this network, blood tests can uncover insulin resistance early—often before glucose stays high—making the hidden workload on the pancreas visible and highlighting metabolic stress linked to fatty liver and heart risk. Over time, these biomarkers show whether lifestyle or medicines are restoring tissue responsiveness (insulin sensitivity).

Why Catching Insulin Resistance Early Matters

Insulin resistance biomarkers reveal how well your cells respond to insulin’s signal to move and store fuel, reflecting the health of the pancreas, liver, muscle, fat tissue, and blood vessels. Early resistance pushes insulin higher, promotes fat storage and inflammation, and precedes diabetes, fatty liver, heart disease, and reproductive disorders such as PCOS.In routine testing, fasting glucose typically falls 70–99, and fasting insulin roughly 2–25. For metabolic risk, values toward the lower end of normal reflect better sensitivity. Higher insulin with normal glucose often means compensation; rising glucose marks impaired fasting control. The TyG index, from fasting triglycerides and glucose, summarizes liver–adipose–muscle insulin action; lower scores are favorable, higher scores suggest resistance. Cutoffs vary by population.When these markers run low, it usually signals efficient insulin signaling: low‑normal insulin, normal‑low glucose, and a low TyG align with steady energy, stable appetite, and less visceral fat. Exceptionally low glucose can cause shakiness, sweating, and confusion, more often in children, during pregnancy, or with glucose‑lowering medications. Very low insulin paired with high glucose indicates insulin deficiency rather than sensitivity.Big picture, insulin, glucose, and TyG sit at the crossroads of metabolism, integrating with lipids, liver enzymes, blood pressure, waist size, and reproductive hormones. They forecast risks to the heart, liver, kidneys, eyes, and brain years before symptoms, linking everyday energy and weight patterns to long‑term outcomes like diabetes, fatty liver, and cardiovascular disease.

What an Insulin-Resistance Panel Can and Can't Clarify

Insulin resistance blood testing provides a window into how efficiently your body manages energy, with far-reaching effects on metabolism, cardiovascular health, brain function, reproductive balance, and immune resilience. At Superpower, we assess insulin resistance using three key biomarkers: Insulin, Glucose, and the Triglyceride-Glucose (TyG) Index. Together, these markers help reveal how well your body responds to insulin—a hormone central to moving glucose from your bloodstream into your cells for fuel.Insulin is a hormone produced by the pancreas that signals cells to absorb glucose. Glucose is the main sugar circulating in your blood, serving as a primary energy source. The TyG Index combines fasting triglyceride and glucose levels to provide a sensitive estimate of insulin resistance. When cells become less responsive to insulin, both insulin and glucose levels can rise, and the TyG Index increases, signaling that the body is working harder to maintain stable blood sugar.Healthy insulin, glucose, and TyG Index values suggest that your body is efficiently using insulin to keep blood sugar stable, supporting steady energy, vascular health, and balanced metabolism. When these markers are elevated, it may indicate that your cells are struggling to respond to insulin, which can disrupt energy balance and stress multiple organ systems over time.Interpretation of these biomarkers can be influenced by factors such as age, pregnancy, acute illness, certain medications, and laboratory assay differences. These variables should be considered when evaluating results to ensure an accurate understanding of your metabolic health.